192 related articles for article (PubMed ID: 30940309)
1. The dipeptidyl peptidase-4 inhibitor sitagliptin ameliorates renal injury in type 1 diabetic mice
Li L; Lian X; Wang Z; Zheng J; Liu J; Chu Y; Teng Y; Zhang Z
Pharmazie; 2019 Apr; 74(4):239-242. PubMed ID: 30940309
[TBL] [Abstract][Full Text] [Related]
2. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
[TBL] [Abstract][Full Text] [Related]
3. Influence of Dipeptidyl Peptidase-IV Inhibitor Sitagliptin on Extracellular Signal-Regulated Kinases 1/2 Signaling in Rats with Diabetic Nephropathy.
Ren X; Liu G; Wang Y; Zhang W; Xue F; Li R; Yu W
Pharmacology; 2017; 100(1-2):1-13. PubMed ID: 28329747
[TBL] [Abstract][Full Text] [Related]
4. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
Li Z; Hong Z; Peng Z; Zhao Y; Shao R
Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584
[TBL] [Abstract][Full Text] [Related]
5. The dipeptidyl peptidase 4 inhibitor sitagliptin improves oxidative stress and ameliorates glomerular lesions in a rat model of type 1 diabetes.
Marques C; Gonçalves A; Pereira PMR; Almeida D; Martins B; Fontes-Ribeiro C; Reis F; Fernandes R
Life Sci; 2019 Oct; 234():116738. PubMed ID: 31398418
[TBL] [Abstract][Full Text] [Related]
6. Betanin, isolated from fruits of Opuntia elatior Mill attenuates renal fibrosis in diabetic rats through regulating oxidative stress and TGF-β pathway.
Sutariya B; Saraf M
J Ethnopharmacol; 2017 Feb; 198():432-443. PubMed ID: 28111218
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
[TBL] [Abstract][Full Text] [Related]
8. Effect of siglidine on glucose lipid metabolism and the expression of iNOS and GLP-1 receptors in diabetic rats.
Zhang HY; Li Y; Zhong YH; Ruan LB; Yang TR; Yin HP
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8984-8989. PubMed ID: 30575943
[TBL] [Abstract][Full Text] [Related]
9. Modulating impacts of quercetin/sitagliptin combination on streptozotocin-induced diabetes mellitus in rats.
Eitah HE; Maklad YA; Abdelkader NF; Gamal El Din AA; Badawi MA; Kenawy SA
Toxicol Appl Pharmacol; 2019 Feb; 365():30-40. PubMed ID: 30576699
[TBL] [Abstract][Full Text] [Related]
10. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
[TBL] [Abstract][Full Text] [Related]
11. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes.
Gangadharan Komala M; Gross S; Zaky A; Pollock C; Panchapakesan U
Nephrology (Carlton); 2016 May; 21(5):423-31. PubMed ID: 26375854
[TBL] [Abstract][Full Text] [Related]
12. Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats.
Tian W; Lei H; Guan R; Xu Y; Li H; Wang L; Yang B; Gao Z; Xin Z
Drug Des Devel Ther; 2015; 9():5147-57. PubMed ID: 26379427
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Effects of Mitiglinide and Glibenclamide Administered in Combination with the Dipeptidyl Peptidase-IV Inhibitor Sitagliptin in Rats with Streptozotocin-Nicotinamide-Induced Type 2 Diabetes.
Akahane K; Ojima K; Yokoyama A; Inoue T; Kiguchi S; Tatemichi S; Takeda H; Kobayashi M
Drug Res (Stuttg); 2017 Jul; 67(7):396-403. PubMed ID: 28486736
[TBL] [Abstract][Full Text] [Related]
14. Sitagliptin inhibits endothelin-1 expression in the aortic endothelium of rats with streptozotocin-induced diabetes by suppressing the nuclear factor-κB/IκBα system through the activation of AMP-activated protein kinase.
Tang ST; Su H; Zhang Q; Tang HQ; Wang CJ; Zhou Q; Wei W; Zhu HQ; Wang Y
Int J Mol Med; 2016 Jun; 37(6):1558-66. PubMed ID: 27122056
[TBL] [Abstract][Full Text] [Related]
15. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
[TBL] [Abstract][Full Text] [Related]
16. Sitagliptin ameliorates diabetic nephropathy by upregulating renal nephrin and podocin expression through modulation of adipokines levels.
Ashraf A; Akhtar T; Shabbir A; Aftab U; Shahzad M
Fundam Clin Pharmacol; 2023 Jun; 37(3):549-555. PubMed ID: 36594370
[TBL] [Abstract][Full Text] [Related]
17. DPP-4 Inhibition Leads to Decreased Pancreatic Inflammatory Profile and Increased Frequency of Regulatory T Cells in Experimental Type 1 Diabetes.
Davanso MR; Caliari-Oliveira C; Couri CEB; Covas DT; de Oliveira Leal AM; Voltarelli JC; Malmegrim KCR; Yaochite JNU
Inflammation; 2019 Apr; 42(2):449-462. PubMed ID: 30707388
[TBL] [Abstract][Full Text] [Related]
18. Preventive effects of rutin on the development of experimental diabetic nephropathy in rats.
Hao HH; Shao ZM; Tang DQ; Lu Q; Chen X; Yin XX; Wu J; Chen H
Life Sci; 2012 Nov; 91(19-20):959-67. PubMed ID: 23000098
[TBL] [Abstract][Full Text] [Related]
19. Effects of dipeptidyl peptidase-4 inhibitors on transforming growth factor-β1 signal transduction pathways in the ovarian fibrosis of polycystic ovary syndrome rats.
Wang F; Zhang ZF; He YR; Wu HY; Wei SS
J Obstet Gynaecol Res; 2019 Mar; 45(3):600-608. PubMed ID: 30515927
[TBL] [Abstract][Full Text] [Related]
20. Eucommia bark (Du-Zhong) improves diabetic nephropathy without altering blood glucose in type 1-like diabetic rats.
Niu HS; Liu IM; Niu CS; Ku PM; Hsu CT; Cheng JT
Drug Des Devel Ther; 2016; 10():971-8. PubMed ID: 27041999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]